The pharmaceutical world is abuzz with the introduction of retatrutide, a new dual GIP and GLP-1 receptor-based medication anticipated to revolutionize the landscape to weight reduction . Preliminary clinical trials suggest this therapy offers significant benefits over existing treatments, potent